+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Aerie Pharmaceuticals - logo

Aerie Pharmaceuticals is a company that focuses on the development and commercialization of therapies for the treatment of glaucoma and other eye diseases. The National Eye Institute expects the number of people in the United States suffering from glaucoma to reach 4.3 million by 2030. Aerie was founded in 2005 and went in public in 2013, raising $67 million in its IPO. Its product candidates include Rhopressa and Roclatan. The company is headquartered in Irvine, California.

From
Global Fuchs Dystrophy - Pipeline Insight, 2022 - Product Thumbnail Image

Global Fuchs Dystrophy - Pipeline Insight, 2022

  • Drug Pipelines
  • August 2022
  • 60 Pages
  • Global
From
From
From
Ophthalmic Drugs Market - Forecasts from 2020 to 2025 - Product Thumbnail Image

Ophthalmic Drugs Market - Forecasts from 2020 to 2025

  • Report
  • April 2020
  • 120 Pages
  • Global
From
From
From
From
Psoriasis - Pipeline Review, H2 2020 - Product Thumbnail Image

Psoriasis - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 956 Pages
  • Global
From
Glaucoma - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Glaucoma - Global Drug Forecast and Market Analysis to 2030

  • Report
  • January 2022
  • 160 Pages
  • Global
From
Keratoconjunctivitis sicca (Dry Eye) - Pipeline Review, H2 2020 - Product Thumbnail Image

Keratoconjunctivitis sicca (Dry Eye) - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 359 Pages
  • Global
From
Glaucoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Glaucoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 385 Pages
  • Global
From
Blepharitis - Pipeline Review, H2 2020 - Product Thumbnail Image

Blepharitis - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 63 Pages
  • Global
From
Ocular Hypertension - Pipeline Review, H2 2020 - Product Thumbnail Image

Ocular Hypertension - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 145 Pages
  • Global
From
Diabetic Macular Edema - Pipeline Review, H2 2020 - Product Thumbnail Image

Diabetic Macular Edema - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 319 Pages
  • Global
From
Loading Indicator